MAP-ID · Multilevel approaches to understanding chronic inflammatory diseases.
„Хоризонт Европа“ — Действия „Мария Склодовска-Кюри“
- Период
- 2025-04-01 → 2030-03-31
- Финансиране от ЕС
- 1 747 200 €
- Участници
- 21
- Схема
- HORIZON-TMA-MSCA-Cofund-D
Линиите свързват координатора с партньорите.
Накратко на български
Хроничните възпалителни заболявания, като рак, алергии и автоимунни разстройства, се изучават чрез молекулярна биология и биоинформатика. Разбирането на тези сложни процеси помага за развитието на новите методи за диагностика и терапия в медицината.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Цел на проекта
The MAP-ID project aims to deliver an East-West Europe-integrating training programme for PhD students, focused on tackling one of the most challenging, complex, and therapeutically unmet problems which are chronic inflammatory diseases. MAP-ID will train chronic inflammation-oriented researchers to become leaders in the field in regional, national, and international arenas. Within the doctoral programme, 13 DCs will conduct their research under the supervision of prominent specialists from the Faculty of Biochemistry, Biophysics, and Biotechnology, Jagiellonian University in Poland (JU), in collaboration with international partner academic institutions and biotech companies. MAP-ID focuses on multilevel approaches to understanding chronic inflammatory diseases, including infectious, autoimmune, allergic disorders, and cancer. To achieve this goal, the programme will establish and strengthen ties and collaborations between JU and top Universities and non-academic partners in Europe and beyond. MAP-ID aims to foster interdisciplinary research spanning molecular, cell, and structural biology, biophysics, chemistry, pharmaceutical sciences, and bioinformatics with a significant contribution of OMICS data sets. The training will give the DCs a detailed insight into the strategies and mechanisms required to contribute to growth in the sector of academic and industrial research related to chronic inflammatory disease research and development. The training will include courses conducted by both host institution researchers and visiting scientists from world-leading Universities and companies. Some of the courses offered for DCs, created specifically for MAP-ID, will be accessible to other JU researchers, enriching the learning resources available to them. Therefore, the MAP-ID will have a significant impact on the JU community and its public image, enabling JU to strengthen its position as a leader in chronic inflammation-related research in central Europe.
Оригинален текст от CORDIS (на английски).
Участници
- UNIWERSYTET JAGIELLONSKI · KrakowКоординаторПолша
- ACADEMISCH ZIEKENHUIS GRONINGEN · GroningenНидерландия
- BGI TECH SOLUTIONS (POLAND) Sp. z o.o. · WarszawaПолша
- BOARD OF REGENTS OF NEVADA SYSTEM OF HIGHER EDUCATION · RenoСъединени щати
- Bacteromic · WarsawПолша
- Cambridge Protein Works Limited · CambridgeОбединеното кралство
- FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE · L'Hospitalet De LlobregatИспания
- FUNDACIO UNIVERSITARIA BALMES · VIC BARCELONAИспания
- KATHOLIEKE UNIVERSITEIT LEUVEN · LeuvenБелгия
- MEDIZINISCHE UNIVERSITAT GRAZ · GrazАвстрия
- POLSKI BANK KOMOREK MACIERZYSTYCH S.A. · WarszawaПолша
- PerioTrap Pharmaceuticals GmbH · HalleГермания
- Ryvu Therapeutics S.A. · KrakówПолша
- THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD · OxfordОбединеното кралство
- UNIVERSITA DEGLI STUDI DI PAVIA · PaviaИталия
- UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA · RomaИталия
- UNIVERSITAT ZURICH · ZurichШвейцария
- Virginia Commonwealth University · Richmond, VaСъединени щати
- WPD PHARMACEUTICALS SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA · WarszawaПолша
- West Virginia University · MorgantownСъединени щати
- intoDNA S.A. · KrakówПолша
Връзки
Данни: CORDIS, © Европейски съюз